Numark Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NUMARK
NUMARK has three approved drugs.
Summary for Numark
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 1 |
| NDAs: | 3 |
Drugs and US Patents for Numark
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Numark | SPRX-105 | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 088024-001 | Dec 22, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Numark | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 083790-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Numark | MELFIAT | phendimetrazine tartrate | TABLET;ORAL | 083790-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Numark | MELFIAT-105 | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 087487-001 | Oct 13, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
